MAGE-2 (127-136)

MAGE-2 (127-136) is a synthetic peptide fragment derived from the melanoma-associated antigen gene family, specifically corresponding to amino acid residues 127 through 136 of the MAGE-2 protein. As a short, well-defined peptide sequence, it serves as a valuable tool for research into antigenic epitopes, protein-protein interactions, and immune recognition mechanisms. Its precise composition and origin within a cancer-testis antigen family member make it particularly relevant for investigations into tumor antigenicity, immunological profiling, and peptide-based assay development in the context of cancer biology and immunology.

Epitope mapping: Researchers utilize this peptide fragment to analyze and define the specific antigenic determinants recognized by antibodies or T-cell receptors. Its sequence enables detailed mapping of linear epitopes on the MAGE-2 protein, facilitating the identification of immunodominant regions involved in immune surveillance or autoimmunity. Such studies are critical for understanding the molecular basis of immune recognition and for guiding the design of more targeted immunological assays.

Immunological assay development: The peptide is frequently employed as a standard or capture agent in various immunoassays, including enzyme-linked immunosorbent assays (ELISA) and T-cell activation assays. Its defined sequence allows for the reproducible detection and quantification of immune responses directed against MAGE-2-derived epitopes, supporting the development of robust screening platforms for basic research, vaccine development, or immunomonitoring studies.

T-cell response characterization: In cellular immunology, the peptide is used to stimulate peripheral blood mononuclear cells (PBMCs) or established T-cell lines, enabling the functional assessment of antigen-specific T-cell responses. By presenting this defined epitope, investigators can dissect the specificity, magnitude, and phenotype of T-cell populations reactive to MAGE-2, thereby advancing the understanding of tumor immunogenicity and the mechanisms underlying immune escape.

Peptide-protein interaction studies: The MAGE-2 (127-136) sequence serves as a model substrate for examining the binding properties of MAGE family proteins or their interacting partners. Through in vitro binding assays or structural analyses, researchers can elucidate the molecular interactions that govern protein complex formation, stability, and function, contributing to the broader field of cancer-testis antigen biology and the discovery of novel regulatory mechanisms.

Peptide synthesis and optimization: As a representative segment of the MAGE-2 protein, this peptide is also relevant for studies focused on synthetic peptide optimization, including modifications that enhance stability, solubility, or immunogenicity. Such work supports the rational design of custom peptides for research applications, including the generation of affinity reagents, the development of peptide libraries, or the improvement of peptide-based detection technologies.

Collectively, these application directions underscore the versatility and scientific value of this peptide fragment within immunological, biochemical, and molecular research settings. Its use enables precise interrogation of antigenic features, supports the development of innovative analytical methods, and provides a foundation for advancing knowledge in tumor immunology and peptide science.

1. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling